This report provides key information on the Infectious Immunology market in the BRICS countries and also provides value ($m) data for each segment and sub-segment of five market categories which include Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology.
Lewes, DE -- (SBWIRE) -- 01/28/2013 -- The report also provides key data on company shares and distribution shares for the overall Infectious Immunology market in each of the BRICS countries and also covers global corporate-level profiles of the key market participants with information on key developments.
“Forecast on Infectious Immunology Market in BRICS (Brazil, Russia, India, China, South Africa) – 2018” is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Inquire about this report: Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
According to the report, the emerging economies of BRICS countries with significantly large pool of under-served patients represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
Why is this report essential?
The report is particularly useful to develop business strategies by identifying the key market categories and segments poised for strong growth, develop market-entry and market expansion strategies, design competition strategies by identifying who-stands-where in the Infectious Immunology competitive landscape in BRICS, develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future, and to Identify, understand and capitalize the key distribution channels and the most preferred mode of product distribution.
The report covers many important topics such as market size data for Infectious Immunology market categories – Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology, annualized market revenues ($m) data for each of the segments and sub-segments within the five market categories from 2004 to 2011, forecast forward for seven years to 2018, 2011 company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries, and global corporate-level profiles of key companies operating within the Infectious Immunology market in BRICS.
The report also gives important data about major industry players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd., Shanghai Kehua Bio-engineering Co., Ltd., Siemens Healthcare, bioMerieux S.A., DiaSorin S.p.A, Qiagen N.V., Transasia Bio-Medicals Ltd., Alere Inc., Beckman Coulter, Inc., Gen-Probe Incorporated, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Trivitron Healthcare Pvt Ltd., Span Diagnostics Ltd., Thermo Fisher Scientific Inc., Tulip Diagnostics (P) Ltd, Cellestis Limited, Chembio Diagnostics, Inc. and Hologic, Inc.
Contact Us For Custom Market Research Requirements.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)